Insider Transactions in Q3 2021 at Statera Biopharma, Inc. (STAB)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2021
|
Taunia Markvicka Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Sep 09
2021
|
Randy S. Saluck Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+49.94%
|
-
|
|
Sep 09
2021
|
Lea Verny Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+50.0%
|
-
|
|
Sep 09
2021
|
Steve K Barbarick Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+50.0%
|
-
|
|
Jul 27
2021
|
Michael K Handley President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
296,609
+50.0%
|
-
|
|
Jul 27
2021
|
Peter Aronstam Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
141,370
+50.0%
|
-
|
|
Jul 27
2021
|
Cozette M. Mc Avoy Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,947
+50.0%
|
-
|
|
Jul 27
2021
|
Clifford Selsky Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
101,579
+50.0%
|
-
|
|
Jul 27
2021
|
Robert Buckheit Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,378
+50.0%
|
-
|
|
Jul 22
2021
|
Langdon L Miller Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$30,000
$3.0 P/Share
|